<DOC>
	<DOCNO>NCT02650102</DOCNO>
	<brief_summary>The aberrant expression micro-RNAs ( miRNAs ) describe many human disease , include schizophrenia ( SZ ) . The previous work indicate strong genetic association miRNA-30e precursor ( pre-miR-30e ) risk SZ . However , date , report focus expression level miR-30 family ( miR-30s ) network co-regulation SZ , even response antipsychotic treatment . Given , investigator first construct hybrid miRNA-TF ( transcription factor ) -gene-PPI ( protein-protein interaction ) network focus miR-30s bioinformatics technology . The investigator select several candidate miR-30s key regulator validation . These candidate quantify real-time quantitative PCR ( qRT-PCR ) independent cohort 200 healthy control 200 drug-free SZ patient , among follow 12-week antipsychotic treatment . Furthermore , investigator evaluate correlation change gene expression improvement symptom .</brief_summary>
	<brief_title>The Role miR-30 Family Dysregulation Response Antipsychotic Treatment</brief_title>
	<detailed_description>Schizophrenia one serious mental disorder，which characterize high prevalence rate , high recurrence rate , could increase patient ' disability burden disease . But pathological mechanism far unknown . Until recently , attention focus gene dysregulation hypothesis . The preliminary work laboratory prompt microRNA-30e gene polymorphism expression abnormal may relate schizophrenia . Combined previous study show miRNA disorder involve neurodevelopmental obstacle neuropsychiatric disease , investigator surmise : miR-30e dysregulation impact occurrence development schizophrenia . This study carry multidimensional research use technology neurobiology , molecular genetics , neuroimaging , integrate method molecular , cell , animal human body tracking , : ( 1 ) Explaining transcription regulation mechanism target gene miR-30e , build gene regulatory network schizophrenia core miR-30e . ( 2 ) To investigate pathogenesis miR-30e participate schizophrenia , evaluate clinical value miR-30e peripheral blood disease diagnose , genotyping , predict efficacy end . The object study provide new scientific data research idea explore neurobiological basis schizophrenia , recognize pathophysiological mechanism schizophrenia , ultimately improve strengthen new situation schizophrenia prevention .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Unrelated Han Chinese recruit north China . Drugfree least one month enrollment . Clinical diagnosis schizophrenia accord Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) criterion SZ ( American Psychiatric Association , 1994 ) , rely Chinese Version Modiﬁed Structured Clinical Interview DSMIV TR Axis I Disorders Patient Edition ( SCIDI/P,11/2002 revision ) . Pregnant signiﬁcant medical condition . Unstable psychiatric feature ( e.g. , suicidal feeling ) . A history substance abuse drug addiction within previous 6 month , exception nicotine dependence . Other Axis I comorbid disorder exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>